Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response

BACKGROUND: We retrospectively examined whether different cycles of chemotherapy affected the prognosis of patients who achieved a pathologic complete response (pCR). METHODS: We reviewed data from patients who achieved pCR after neoadjuvant chemotherapy (NACT) between 2008 and 2018. In total, 286 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xianjun, Liu, Yang, Shan, Ming, Xu, Bingqi, Lu, Yubo, Zhang, Guoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798334/
https://www.ncbi.nlm.nih.gov/pubmed/35117465
http://dx.doi.org/10.21037/tcr.2020.01.01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798334/
https://www.ncbi.nlm.nih.gov/pubmed/35117465
http://dx.doi.org/10.21037/tcr.2020.01.01

Ejemplares similares